IntroductionThere is growing evidence that in some circumstances B cells contribute to the maintenance of transplant tolerance [1,2], as well as promoting chronic allograft responses [3][4][5]. In mice, anti-CD20 depletion has been reported to accelerate skin graft rejection [3], and anti-CD45RB-induced tolerance to heart transplants requires Correspondence: Prof. Giovanna Lombardi e-mail: giovanna.lombardi@kcl.ac.uk the presence of B cells [6]. In rats, long-term allograft tolerance is characterized by an accumulation of B cells expressing genes associated with tolerance [7].We have recently reported that immunosuppressant-free transplant patients who were spontaneously tolerant to transplanted HLA-mismatched kidneys had a "B-cell signature" [8]. Compared to healthy controls and nontolerant patients, tolerant recipients * These authors contributed equally to this study. * * These authors contributed equally to this study as senior authors.C 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.eji-journal.eu
844Aurélie Moreau et al. Eur. J. Immunol. 2015. 45: 843-853 upregulated genes associated with B-cell function in peripheral blood. Further studies have shown that drug-free tolerant patients maintain transitional B-cell numbers in their peripheral blood at the same levels as healthy individuals, and at higher numbers than stable patients on immunosuppressant or chronic rejectors [9,10]. As previously reported, these transitional B cells may represent a regulatory subset that actively regulates the alloresponse [11]. Regulatory B (Breg) cells have been shown to be important in the maintenance of tolerance in a number of mouse models of autoimmunity [12,13] [17,18]. T2 B cells were transiently expanded in mice tolerized by donor splenocyte transfusion (DST) and anti-CD40L treatment. T2 B cells isolated from tolerized mice, but not from naïve mice, were able to prolong skin graft survival in vivo and suppress T-cell cytokine production in vitro. The ability of tolerized B cells to prolong graft survival was antigen specific and involved cooperation with Treg cells. IL-10 production did not correlate with suppressive capacity, however T2 isolated from tolerized mice displayed enhanced survival in vivo, upregulated TIM-1 expression, but lost CD86 expression.
ResultsTransfer of tolerized B cells prolongs skin allograft survival in an antigen-specific manner C57BL/6 mice can be rendered tolerant to skin transplants from MHC class I mismatched C57BL/6. (Fig. 1D).Neither transfer of splenic non-B cells nor B cells from naïve mice, previously shown to be effective in autoimmune models but not effective in transplantation models [14,15,21], was able to prolong graft survival. Transfer of B cells from tolerant mice also significantly reduced the amount of IgG anti-K d alloantibody present in the serum of recipient mice ( Fig. 1E and F). In addition, the transfer of 10 × 10 6 tolerized B cells was able to prolong skin graft survival significantly longer than transfer of 2 × 10 6 tolerized B cells (Fig. 1G). We next t...